Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Instagram
Telegram
LinkedIn

Barcha huquqlar himoyalangan.

Foydalanish shartlari

Bosh sahifa
Bozorlar
Skriner
Yangiliklar
Biz haqimizda

MDBH - MDB Capital Holdings, LLC So'nggi... | Finranks

Home

MDBH

M

MDB Capital Holdings, LLC (MDBH)

NCM – Real vaqt narxi. Valyuta: USD

2.98

+0.02 (0.67%)

Yopilishda: Mar 27, 2026, 4:00 PM EDT

3.01

+0.03 (1.01%)

Bozordan keyin: Mar 27, 2026, 4:10 PM EDT

Umumiy
Yangiliklar
Grafik
Hisobotlar
Dividendlar
Kutilma
Egalik
Profil

MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time

MDB Capital Holdings to Host Fourth Quarter and Full Year 2025 Results Conference Call on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time

Addison, TX, March 23, 2026 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading disruptive technology companies, plans to host a Zoom webinar on Tuesday, March 31, 2026 at 4:30 p.m. Eastern Time to discuss its results for the fourth quarter and full year 2025. A press release detailing the results will be issued prior to the call.

PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics

PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics

Dallas, TX, March 11, 2026 (GLOBE NEWSWIRE) -- PatentVest announced the completion of a strategic intellectual property engagement with Porosome Therapeutics, Inc., a biotechnology company developing a first-in-class therapeutic platform designed to restore cellular secretion mechanisms.

PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race

PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race

Analysis of 1,200+ patent documents reveal which programs are building durable exclusivity, and which may not be Analysis of 1,200+ patent documents reveal which programs are building durable exclusivity, and which may not be

MDB Capital Holdings Announces Transitions In Its Board of Directors

MDB Capital Holdings Announces Transitions In Its Board of Directors

MDB Capital Holdings Announces Transitions In Its Board of Directors Jeb Terry, Sr. appointed to the board as Susanne Meline concludes dedicated and impactful board service MDB Capital Holdings Announces Transitions In Its Board of Directors Jeb Terry, Sr. appointed to the board as Susanne Meline concludes dedicated and impactful board service

PatentVest Releases New Report on the IP Battle Shaping the $1.8 Trillion Space Economy

PatentVest Releases New Report on the IP Battle Shaping the $1.8 Trillion Space Economy

New PatentVest Pulse analysis examines Elon Musk's SpaceX, Jeff Bezos–backed Blue Origin, Rocket Lab, and China's growing influence New PatentVest Pulse analysis examines Elon Musk's SpaceX, Jeff Bezos–backed Blue Origin, Rocket Lab, and China's growing influence

Keiretsu Forum and MDB Capital Close 2025 With High-Impact Investor Summits, and Announces Expanded Summit Series for 2026

Keiretsu Forum and MDB Capital Close 2025 With High-Impact Investor Summits, and Announces Expanded Summit Series for 2026

Keiretsu Forum MST and MDB Capital united 150+ investors to improve syndication and exits, and will expand the Investor Summit series nationwide in 2026.

MDB Capital Holdings, LLC (MDBH) Q3 2025 Earnings Call Transcript

MDB Capital Holdings, LLC (MDBH) Q3 2025 Earnings Call Transcript

MDB Capital Holdings, LLC ( MDBH ) Q3 2025 Earnings Call November 20, 2025 4:30 PM EST Company Participants Tony Dammicci Christopher Marlett - Co-Founder, CEO & Chairman George Brandon - President, Head of Community Development & Director Presentation Tony Dammicci Welcome everyone to the MDB Capital Holdings' Third Quarter 2025 Update Conference Call. Thanks so much for joining us today.

Videolar

No Data

There is no data to display

Press-relizlar

PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics

PatentVest Announces Strategic Intellectual Property Collaboration with Porosome Therapeutics to Strengthen Platform for Secretory Disorder Therapeutics

Dallas, TX, March 11, 2026 (GLOBE NEWSWIRE) -- PatentVest announced the completion of a strategic intellectual property engagement with Porosome Therapeutics, Inc., a biotechnology company developing a first-in-class therapeutic platform designed to restore cellular secretion mechanisms.

PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race

PatentVest Releases New Report on The Oral Small-Molecule GLP-1 Patent Race

Analysis of 1,200+ patent documents reveal which programs are building durable exclusivity, and which may not be Analysis of 1,200+ patent documents reveal which programs are building durable exclusivity, and which may not be

MDB Capital Holdings Announces Transitions In Its Board of Directors

MDB Capital Holdings Announces Transitions In Its Board of Directors

MDB Capital Holdings Announces Transitions In Its Board of Directors Jeb Terry, Sr. appointed to the board as Susanne Meline concludes dedicated and impactful board service MDB Capital Holdings Announces Transitions In Its Board of Directors Jeb Terry, Sr. appointed to the board as Susanne Meline concludes dedicated and impactful board service

PatentVest Releases New Report on the IP Battle Shaping the $1.8 Trillion Space Economy

PatentVest Releases New Report on the IP Battle Shaping the $1.8 Trillion Space Economy

New PatentVest Pulse analysis examines Elon Musk's SpaceX, Jeff Bezos–backed Blue Origin, Rocket Lab, and China's growing influence New PatentVest Pulse analysis examines Elon Musk's SpaceX, Jeff Bezos–backed Blue Origin, Rocket Lab, and China's growing influence